Published by Michele Maatouk on 18th April 2024
(Sharecast News) - HSBC initiated coverage of Haleon on Thursday with a 'buy' rating and 370p price target as it took a look at consumer health stocks, saying the company stands out for its portfolio strength, the quality of its execution and better potential for exploiting new growth avenues.
URL: http://www.digitallook.com/dl/news/story/34230793/...